HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amazon Flexes E-Commerce Heft By Imposing Quality-Control Requirements For Supplements

Executive Summary

Amazon requires firms selling supplements on its site in the US to demonstrate their products comply with FDA regulations for labeling and GMPs. Marketers that don’t submit documentation face removal of their products from the site.

You may also be interested in...



Drug-Spiked Supplements Spread During US Holidays; Excess Yohimbine In Gorilla Root Juice

Reminding consumers in somewhat an end-of-year tradition about drug-spiked supplements, FDA also says “dangerous” levels of yohimbine found in Green Gorilla Root Juice prompted recall. Agency also suggests retailers get more involved in preventing sales of drug-spiked products labeled as supplements.

Like Other Outbreaks, Coronavirus Symptoms Include False Health Claims, Price-Gouging

FDA isn't alone monitoring drug, medical device and food companies making false Covid-19 treatment claims. New York AG warns Jim Bakker, UK agency cuts off face mask ads, Amazon removes thousands of products priced to cheat fearful consumers and Facebook cuts false ads.

CVS Standards: Another Step In Supplement Industry Transparency Evolution

CVS Pharmacy is developing standards, including third-party tests, for vitamins and supplements sold in its stores. Targeted for implementation by 2019, the standards are part of a health care-focused effort in which the firm will expand its lineup of vitamins and supplements.

Topics

UsernamePublicRestriction

Register

OM011381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel